Patient-based drug discovery's latest news

Lamiable, A., Champetier, T., Leonardi, F. et al. Revealing invisible cell phenotypes with conditional generative modeling. Nat Commun 14, 6386 (2023). Biological sciences, drug...

Chatrousse et al., Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9....

Weiss A, Sommer P, Wilbertz JH. Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons. J Vis Exp. 2023 Jul 7;(197). doi: 10.3791/65570. PMID: 37486112...

A new publication of the environMENTAL consortium on effects of urban living environments on mental health in adults has been just in the prestigious journal Nature Medicine The...

Link to publication: https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(22)00423-4  In our most recent work in collaboration with colleagues from Life & Brain and the...

Ksilink is dedicated to foster patient-based therapeutic approaches including personalized strategies as a means to stratify potential targeted therapies in a clinically relevant...

Dr YongJun Kwon, Ksilink’s Head of Early Discovery and Technology Development, publishes a paper entitled “Pharmacogenomic landscape of patient-derived tumor cells informs...